FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to neurology, and may be used for treating spasticity accompanied by improved consciousness in the patients in the vegetative state. That is ensured by administering Xeomin (botulinumtoxinA free from complexing proteins) into the spastic muscles of all the extremities and related body segments regardless of the contractions in total dose of 400-1300 units. The dose shall not exceed 24 unit/kg of body weight in 1-3 stages. The stages follow at least every 3 days. Every 1-day stage involves administering 5-50 units in each accessible muscle or muscle group with the maximum tone in max. total dose 500 units dissolved in 12.5 unit/ml. The injections are distributed uniformly along the area without electromyography. The following courses are similar if observing spasticity and/or if clinically reasonable. The length of one course is up to 3 weeks.
EFFECT: method enables improving the therapeutic effect in the vegetative states.
3 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF HAND SPASTICITY IN PATIENTS WITH CHRONIC IMPAIRMENT OF CONSCIOUSNESS | 2020 |
|
RU2755579C1 |
METHOD OF TREATING MUSCULAR TONIC DISORDERS OF CHEWING MUSCULATURE | 2019 |
|
RU2731694C1 |
METHOD FOR RELIEVING SPASTIC SYNDROME ACCOMPANYING INFANTILE CEREBRAL PARALYSIS | 2013 |
|
RU2531468C1 |
METHOD OF TREATING VEGETATIVE STATE | 2011 |
|
RU2506968C2 |
METHOD OF SURGICAL TREATMENT OF MUSCULAR DYSTONIA OF LOWER EXTREMITIES | 2011 |
|
RU2489110C2 |
METHOD FOR TREATMENT OF SPASTICITY WITH MUSCLE FIBROSIS IN CHILDREN | 2020 |
|
RU2755762C1 |
METHOD FOR REHABILITATION OF CHILDREN WITH SPASTIC INFANTILE CEREBRAL PARALYSIS AFTER BOTULINUM TOXIN THERAPY | 2015 |
|
RU2591840C1 |
METHOD OF SURGICAL TREATMENT OF HETEROTOPIC OSSIFICATION WITH THE IMPLEMENTATION OF NEURAL NETWORK MODELING OF THE SPASTIC SYNDROME OF PATIENT | 2016 |
|
RU2672385C2 |
METHOD OF TREATING MUSCLE SPASTICITY IN PATIENTS WITH VERTEBRAL AND SPINAL CORD INJURY | 2011 |
|
RU2454170C1 |
HIGH INTRODUCTION RATE OF NEUROTOXIC COMPONENT OF BOTULINUM TOXIN | 2007 |
|
RU2453333C2 |
Authors
Dates
2013-12-27—Published
2012-11-20—Filed